Tania Melina Rodriguez

Title: Innovations by Tania Melina Rodriguez in Cancer Treatment

Introduction

Tania Melina Rodriguez is an accomplished inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of medical research, particularly through her innovative work related to treatments for cancer and hepatic fibrosis. With one patent to her name, Rodriguez stands out as a notable figure in the research community.

Latest Patents

Rodriguez holds a patent for the invention titled "TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro." This patent describes an isoform of the TGF beta receptor II, which includes a sequence of about 80 amino acids and lacks a transmembrane domain. The patent specifies that the isoform may include the amino acid sequence set forth in SEQ ID No. 2 or variants that maintain at least 85% sequence identity to it. The invention presents a fusion peptide that incorporates the TGF beta II receptor isoform fused to a ligand and discusses its application in therapeutic treatments for cancer and hepatic fibrosis, utilizing a vector containing the fusion peptide. Additionally, it introduces an antibody that binds to the soluble isoform of the TGF beta II receptor, particularly targeting the amino acid sequence shown in SEQ ID No. 12, which is useful in various in vitro methods.

Career Highlights

Throughout her career, Tania Melina Rodriguez has collaborated with prominent research institutions such as the National Scientific and Technical Research Council (Consejo Nacional de Investigación Científica y Técnica) and the Fundación Articula. Her work has primarily focused on the intersection of biochemical research and therapeutic applications, aiming to develop effective treatment methods for serious health conditions.

Collaborations

Rodriguez has worked alongside renowned colleagues, including Ana Romo and Anabela Belen La Colla. Their combined expertise in medical and scientific research has contributed to the advancements in their respective fields, showcasing the importance of collaboration in innovation and invention.

Conclusion

Tania Melina Rodriguez continues to make strides in medical research with her innovative approaches to treatment for cancer and hepatic fibrosis. With her patent on the TGF beta receptor isoform and its applications, she exemplifies the impact that dedicated inventors can have in improving health outcomes. Rodriguez's contributions reflect the spirit of innovation that is crucial in today’s scientific landscape.